Théo Ebermeyer
University of Lyon
9 Papers
1 Citations
Théo Ebermeyer is an academic researcher from University of Lyon. The author has contributed to research in topics: Medicine & Chemistry. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Platelets as Key Factors in Inflammation: Focus on CD40L/CD40
Fabrice Cognasse,Anne-Claire Duchez,Estelle Audoux,Théo Ebermeyer,Charles-Antoine Arthaud,Amélie Prier,Marie-Ange Eyraud,Patrick Mismetti,Olivier Garraud,Laurent Bertoletti,Hind Hamzeh-Cognasse +10 more
TL;DR: All of the studies presented in this review show that platelets are capable of covering most of the stages of inflammation, primarily through the CD40L/CD40 interaction, thus confirming their own role in this pathophysiological condition.
Platelet Innate Immune Receptors and TLRs: A Double-Edged Sword.
Théo Ebermeyer,Fabrice Cognasse,Philippe Berthelot,Patrick Mismetti,Olivier Garraud,Hind Hamzeh-Cognasse +5 more
TL;DR: An overview of platelet functions can be found in this article, where it is shown that platelets are sentinels actively participating in the immuno-surveillance of the body.
49
Inflammatory markers and auto-Abs to type I IFNs in COVID-19 convalescent plasma cohort study
Fabrice Cognasse,Hind Hamzeh-Cognasse,Mickael Rosa,Delphine Corseaux,Brigitte Bonneaudeau,Chloé Pierre,Julie Huet,Charles-Antoine Arthaud,Marie-Ange Eyraud,Amélie Prier,Anne-Claire Duchez,Théo Ebermeyer,Marco Heestermans,Estelle Audoux-Caire,Quentin Philippot,Tom Le Voyer,Olivier Hequet,Anne-Marie Fillet,Patricia Chavarin,D. Legrand,P. Richard,F. Pirenne,Pierre Gallian,Jean-Laurent Casanova,Sophie Susen,Pascal Morel,Karine Lacombe,Paul Bastard,Pierre Tiberghien +28 more
TL;DR: In this paper , the authors compared COVID-19 convalescent plasma (CCP) with non-convalescent control plasma (n = 166) for soluble inflammatory markers, ex-vivo inflammatory bioactivity on endothelial cells, neutralising auto-Abs to type I IFNs and reported adverse events in the recipients.
9
Inflammatory Markers and Auto-Abs to Type I IFNs in COVID-19 Convalescent Plasma
Fabrice Cognasse,Hind Hamzeh-Cognasse,Mickael Rosa,Delphine Corseaux,Brigitte Bonneaudeau,Chloé Pierre,Julie Huet,Charles-Antoine Arthaud,Marie-Ange Eyraud,Amélie Prier,Anne-Claire Duchez,Théo Ebermeyer,Marco Heestermans,Estelle Audoux-Caire,Quentin Philippot,Tom Le Voyer,Olivier Hequet,Anne-Marie Fillet,Patricia Chavarin,D. Legrand,P. Richard,F. Pirenne,Pierre Gallian,Jean-Laurent Casanova,Sophie Susen,Pascal Morel,Karine Lacombe,Paul Bastard,Pierre Tiberghien +28 more
TL;DR: In this paper , the authors compared COVID-19 convalescent plasma (CCP) with non-convalescent blood plasma (n = 766) for soluble inflammatory markers, ex-vivo inflammatory bioactivity on endothelial cells, neutralizing auto-Ab to type I IFNs and reported adverse events in the recipients.
1
The efficacy of therapeutic plasma exchange in COVID-19 patients on endothelial tightness in vitro is hindered by platelet activation
Théo Ebermeyer,Olivier Hequet,Frédéric Bérard,Amélie Prier,Marie-Ange Eyraud,Charles-Antoine Arthaud,Marco Heestermans,Anne-Claire Duchez,Aurélie Guironnet-Paquet,Philippe Berthelot,Fabrice Cognasse,Hind Hamzeh-Cognasse +11 more
TL;DR: In this article , the authors used an in vitro model of platelet-endothelial cell interactions to assess changes in these interactions by plasma from COVID-19 patients and to determine the extent to which TPE reduces such changes.
1